| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 65,688 | 80,221 | 84,207 | 75,582 | | Cost of Revenue | 23,040 | 24,133 | 22,515 | 21,602 | | | Gross Profit |
-
| 56,088 | 61,692 | 53,980 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 39,447 | 34,700 | 30,441 | 43,541 | | Non Recurring | 1,344 | 2,364 | 17,503 | 74,716 | | Others | 60,345 | 70,955 | 63,537 | 94,366 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (51,931) | (49,789) | (158,643) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (58,573) | (51,846) | (49,543) | (158,793) | | Interest Expense | 13,406 | 11,058 | 9,870 | 10,364 | | Income Before Tax | (71,979) | (62,904) | (59,413) | (169,157) | | Income Tax Expense |
-
|
-
| (16,147) | (1,899) | | Minority Interest | (85) | 85 | 246 | (150) | | | | Net Income From Continuing Ops | (71,979) | (62,904) | (43,266) | (167,258) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (71,979) | (62,904) | (43,266) | (167,258) | | Preferred Stock And Other Adjustments | (3,228) | (3,244) | (2,172) |
-
| | | Net Income Applicable To Common Shares | ($75,207) | ($66,148) | ($45,438) | ($167,258) |
|
0.02% Nasdaq 0.00%
Income Statement
